The solution to a widespread shortage of certain antibiotics, painkillers and anesthetics is to declare a 'national pharmacopoeia' an issue of national security, says the editor-in-chief of the Canadian Journal of Surgery.
1
0
When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry—and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, ...
1
0
One of the world's biggest tobacco companies is diving into the cannabis market with a $1.8 billion buy-in.
3
0
A pharmaceutical company has agreed to pay $360 million to resolve allegations that it used a charitable foundation to pay kickbacks to Medicare patients.
0
0
(HealthDay)—All lots of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination blood pressure tablets have been recalled by Teva Pharmaceuticals due to higher-than-acceptable levels of a chemical ...
19
0
The expansive court case seeking to hold drugmakers responsible for the nation's opioid crisis has a new complication: How does it deal with claims covering the thousands of babies born addicted to the drugs?
0
0
When Polly Varnado's 9-year-old daughter was diagnosed with Type 1 diabetes, it didn't take long for the family to hear about insulin pumps.
3
0
(HealthDay)—For patients with primary progressive multiple sclerosis (PPMS), ocrelizumab reduces progression of upper-extremity (UE) impairment, according to an exploratory analysis published online Nov. 12 in the Multiple ...
1
0
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments. That's the opposite of what clinical trials are ...
17
0
For nearly two decades, health advocates have pushed to standardize the way medical devices are tracked and studied.
3
0
